EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Next-generation drug delivery technologies in head and neck cancer: Current therapeutic advances and future perspectives

Mohit Angolkar, Sharanya Paramshetti, Darshan Patil, K M Asha Spandana, Riyaz Ali M Osmani, Hosahalli Veerabhadrappa Gangadharappa, Adel Al Fatease, Ali H Alamri, Umme Hani, Amarjitsing Rajput

Pathology - Research and Practice · 2026-06 · 282 · 156453

DOI: 10.1016/j.prp.2026.156453 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-06. Verfasst von Mohit Angolkar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Elect…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 396 Literaturangaben. Gefördert von: King Khalid University, King Khalid University Deanship of Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinomas (HNSCCs) pose formidable challenges due to their invasive behaviour and the tendency for metastasis, often resulting in dismal prognoses, particularly in advanced stages. However, over the last decade, nanomaterials (NMs) have emerged as promising assets for both diagnosing and treating HNSCCs. NMs provide distinct advantages by enabling the delivery of a wide variety of active moieties, encompassing imaging agents, drugs, genes, vaccines, radiosensitizers, and photosensitizers, thereby revolutionizing the therapeutic landscape of HNSCCs. This comprehensive review delves into recent strides in NMs, aiming to augment the diagnosis, prognosis, and therapy of patients afflicted with HNSCC utilizing advanced drug delivery systems. Harnessing the distinctive properties of NMs, including targeted delivery of drug, controlled and sustained release mechanisms, and responsiveness to stimuli, holds immense potential in enhancing treatment efficacy and impact on patient health. Moreover, we explore the prospect of NMs in facilitating personalized medicine strategies tailored to the needs of individual patient, ushering in a new era of precision oncology. Furthermore, we underscore pivotal areas for future research endeavours in the realm of nanotechnology-enabled HNSCC therapy using various drug delivery systems. By amalgamating nanotechnological breakthroughs, we envision a transformative shift in the therapeutic paradigm for HNSCCs, offering promising avenues for early detection, precise therapy, and ultimately, improved survival rates for patients battling this challenging malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckAntineoplastic AgentsNanostructuresHumansPrecision MedicineAnimals

Stichwörter der Autor:innen

Cancer therapyDrug deliveryHead and neck squamous cell carcinomasNanomaterialsPersonalized medicineTumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Electronic address: mohitangolkar11@gmail.com.
  • Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Electronic address: paramshettisharanya@gmail.com.
  • Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Electronic address: darshanpatilph@gmail.com.
  • Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Electronic address: asha@jssuni.edu.in.
  • Department of Pharmaceutics, College of Pharmacy, King Khalid University (KKU), Al Faraa, Abha 62223, Aseer, Saudi Arabia. Electronic address: maliosmani@kku.edu.sa.
  • Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, Karnataka, India. Electronic address: hvgangadharappa@jssuni.edu.in.

Förderung

  • King Khalid University
  • King Khalid University Deanship of Scientific Research

Zitieren

APA

Angolkar, M., Paramshetti, S., Patil, D., Asha Spandana, K. M., Osmani, R. A. M., Gangadharappa, H. V., Fatease, A. A., Alamri, A. H., Hani, U., & Rajput, A. (2026). Next-generation drug delivery technologies in head and neck cancer: Current therapeutic advances and future perspectives. Pathology - Research and Practice, 282, 156453. https://doi.org/10.1016/j.prp.2026.156453

Vancouver

Angolkar M, Paramshetti S, Patil D, Asha Spandana KM, Osmani RAM, Gangadharappa HV, et al. Next-generation drug delivery technologies in head and neck cancer: Current therapeutic advances and future perspectives. Pathology - Research and Practice. 2026;282:156453. doi:10.1016/j.prp.2026.156453

BibTeX
@article{Angolkar2026,
  author = {Angolkar, Mohit and Paramshetti, Sharanya and Patil, Darshan and Asha Spandana, K M and Osmani, Riyaz Ali M and Gangadharappa, Hosahalli Veerabhadrappa and Fatease, Adel Al and Alamri, Ali H and Hani, Umme and Rajput, Amarjitsing},
  title = {Next-generation drug delivery technologies in head and neck cancer: Current therapeutic advances and future perspectives},
  journal = {Pathology - Research and Practice},
  year = {2026},
  volume = {282},
  pages = {156453},
  doi = {10.1016/j.prp.2026.156453}
}
Kostenlos starten →